Asia-Pacific Obesity Treatment Market

Published Apr 01, 2025

Length 350 Pages

SKU # DAABD20406818

Description

Asia-Pacific obesity treatment market is expected to reach USD 16.72 million by 2032 from USD 5.09 million in 2024, growing at a CAGR of 16.0% in the forecast period of 2025 to 2032.
Market Segmentation:
Asia-Pacific Obesity Treatment Market, By Treatment Type (Pharmacological Treatments (Anti-obesity Drugs), Bariatric Surgery, Behavioral & Lifestyle Therapy, Non-Invasive/ Endoscopic Procedures, and Medical Devices & Technologies), Age Group (Adult Obesity Treatment, Geriatric Obesity Treatment, and Pediatric Obesity Treatment), Distribution Channel (Online Pharmacies, Retail Pharmacies, Weight Management Clinics, Hospital Pharmacies, and Wellness & Fitness Centers), Patient Type (Class III, Class II, and Class I), Country (China, Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, Taiwan, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2032

Overview of Asia- Pacific Obesity Treatment Market Dynamics:

Driver

• Integration of Digital Health Solutions in Obesity Treatment

Restraint

• Anti-Obesity Drugs and Surgical Interventions Carry Risks

Opportunity

• Increasing Prevalence of Lifestyle Related Diseases

Market Players:

The key market players operating in the Asia- Pacific obesity treatment market are listed below:

• Novo Nordisk A/S
• Eli Lilly and Company
• Medtronic Plc.
• Boston Scientific Corporation
• Johnson & Johnson Services, Inc.
• Astrazeneca
• Sanofi
• Allurion Technologies
• GSK plc
• F. HOFFMANN LA-ROCHE AG.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Asia-pacific Obesity Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Multivariate Modelling; 2.6 Treatment Type Lifeline Curve; 2.7 Primary Interviews With Key Opinion Leaders; 2.8 Dbmr Market Position Grid; 2.9 Market End User Coverage Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Porter’s Five Forces; 4.2 Pestel Analysis; 4.3 Epidemiology: Asia-pacific Obesity Treatment Market; 4.4 Drug Treatment Rate By Matured Markets: Asia-pacific Obesity Treatment Market; 4.5 Drug; 4.6 Word Pipeline
5 Regulatory Framework For The Asia-pacific Obesity Treatment Market: 5.1 Regulatory Approval Pathways; 5.2 Licensing And Registration; 5.3 Regulatory Approval Pathways; 5.4 Licensing And Registration; 5.5 Good Manufacturing Practices (Gmps) Guidelines
6 Market Overview: 6.1 Drivers; 6.1.1 Increasing Prevalence Of Obesity; 6.1.2 Innovations In Anti-obesity Medications; 6.1.3 Growth In Bariatric And Metabolic Surgeries.; 6.1.4 Integration Of Digital Health Solutions In Obesity Treatment; 6.2 Restraints; 6.2.1 Anti-obesity Drugs And Surgical Interventions Carry Risks; 6.2.2 High Relapse Rates Post-treatment Of Obesity; 6.3 Opportunities; 6.3.1 Increasing Prevalence Of Lifestyle Related Diseases; 6.3.2 Rising Disposable Income Enhancing The Purchasing Power For Obesity Treatment Related Products; 6.3.3 Rise In Strategic Initiatives And Launches By Market Players; 6.4 Challenges; 6.4.1 Long-term Follow-ups Associated With Obesity Treatment; 6.4.2 Addressal Of The Lifestyle And Behavioral Changes
7 Asia-pacific Obesity Treatment Market, By Treatment Type: 7.1 Overview; 7.2 Pharmacological Treatments (Anti-obesity Drugs); 7.2.1 Glp-1 Receptor Agonists; 7.2.2 Dual Gip/ Glp-1 Receptor Agonists; 7.2.2.1 Phentermine; 7.2.2.2 Phentermine-topiramate; 7.2.2.3 Naltrexone-bupropion; 7.2.3 Lipase Inhibitors; 7.2.4 Deoxycholic Acid; 7.2.5 Others; 7.3 Bariatric Surgery; 7.3.1 Restrictive Surgeries; 7.3.1.1 Sleeve Gastrectomy; 7.3.1.2 Adjustable Gastric Banding; 7.3.2 Combination Surgeries; 7.3.2.1 Roux-en-y Gastric Bypass (Rygb); 7.3.2.2 Mini-gastric Bypass (Mgb); 7.3.3 Malabsorptive Surgeries; 7.3.3.1 Laparoscopic Surgery; 7.3.3.2 Robotic-assisted Surgery; 7.3.3.3 Open Surgery; 7.4 Behavioral & Lifestyle Therapy; 7.4.1 Dietary Interventions; 7.4.2 Behavioral Modification Therapy; 7.4.3 Physical Activity Programs; 7.4.4 Psychological Counseling; 7.5 Non-invasive/ Endoscopic Procedures; 7.5.1 Endoscopic Sleeve Gastroplasty (Esg); 7.5.2 Intragastric Balloon (Igb); 7.5.2.1 Orbera Intragastric Balloon; 7.5.2.2 Spatz Adjustable Balloon System; 7.5.3 Aspiration Therapy (Aspireassist); 7.5.4 Transoral Gastroplasty (Toga); 7.6 Medical Devices & Technologies; 7.6.1 Artificial Intelligence & Digital Weight Management Platforms; 7.6.2 Gastric Electrical Stimulation Devices (Maestro System)
8 Asia-pacific Obesity Treatment Market, By Age Group: 8.1 Overview; 8.2 Adult Obesity Treatment; 8.3 Geriatric Obesity Treatment; 8.4 Pediatric Obesity Treatment
9 Asia-pacific Obesity Treatment Market, By Distribution Channel: 9.1 Overview; 9.2 Online Pharmacies; 9.3 Retail Pharmacies; 9.4 Weight Management Clinics; 9.5 Hospital Pharmacies; 9.6 Wellness & Fitness Centers
10 Asia-pacific Obesity Treatment Market, By Patient Type: 10.1 Overview; 10.2 Class Iii; 10.3 Class Ii; 10.4 Class I
11 Asia-pacific Obesity Treatment Market, By Region: 11.1 Asia-pacific; 11.1.1 China; 11.1.2 Japan; 11.1.3 India; 11.1.4 Australia; 11.1.5 South Korea; 11.1.6 Taiwan; 11.1.7 Singapore; 11.1.8 Malaysia; 11.1.9 Thailand; 11.1.10 Indonesia; 11.1.11 Philippines; 11.1.12 Vietnam; 11.1.13 Rest Of Asia-pacific
12 Asia-pacific Obesity Treatment Market, Company Landscape: 12.1 Company Share Analysis: Asia-pacific
13 Swot Analysis
14 Company Profile: 14.1 Novo Nordisk A/S; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Eli Lilly And Company; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Development/News; 14.3 Medtronic; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development; 14.4 Boston Scientific Corporation; 14.4.1 Company Snapshots; 14.4.2 Revenue Analysis And Segmented Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Johnson & Johnson Services, Inc.; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Development/News; 14.6 Altimmune; 14.6.1 Company Snapshot; 14.6.2 Pipeline Portfolio; 14.6.3 Recent Updates; 14.7 Astrazeneca; 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Development/News; 14.8 Allurion; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 1.1.5 Recent Development/News; 14.9 Amgen; 14.9.1 Company Snapshot; 14.9.2 Revenue Analysis; 14.9.3 Product Portfolio; 1.1.13 Recent Development/News; 14.10 Arena Pharmaceuticals Ltd; 14.10.1 Company Snapshot; 14.10.2 Product Portfolio; 14.10.3 Recent Development; 14.11 Currax Pharmaceuticals Llc; 14.11.1 Company Snapshot; 14.11.2 Product Portfolio; 14.11.3 Recent Development; 14.12 Cousin Surgery; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Development; 14.13 F. Hoffmann-la Roche Ltd; 14.13.1 Company Snapshot; 14.13.2 Revenue Analysis; 14.13.3 Product Portfolio; 14.13.4 Recent Development/News; 14.14 Fitterfly Healthtech Pvt. Ltd.; 14.14.1 Company Snapshot; 14.14.2 Product Portfolio; 14.14.3 Recent Development; 14.15 Morphic Medical, Inc; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Development; 14.16 Noom, Inc.; 14.16.1 Company Snapshot; 14.16.2 Product Portfolio; 14.16.3 Recent Development; 14.17 Omada Health Inc; 14.17.1 Company Snapshot; 14.17.2 Product Portfolio; 14.17.3 Recent Development; 14.18 Reshape Lifesciences; 14.18.1 Company Snapshot; 14.18.2 Revenue Analysis; 14.18.3 Product Portfolio; 1.1.7 Recent Development/News; 14.19 Raziel; 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Spatz Fgia Inc.; 14.20.1 Company Snapshot; 14.20.2 Product Portfolio; 14.20.3 Recent Development; 14.21 Sanofi; 14.21.1 Company Snapshot; 14.21.2 Revenue Analysis; 14.21.3 Product Portfolio; 14.21.4 Recent Development; 14.22 Saniona; 14.22.1 Company Snapshot; 14.22.2 Revenue Analysis; 14.22.3 Product Portfolio; 14.22.4 Recent Development; 14.23 Usgi Medical; 14.23.1 Company Snapshot; 14.23.2 Product Portfolio; 14.23.3 Recent Development; 14.24 Vivus Llc.; 14.24.1 Company Snapshot; 14.24.2 Product Portfolio; 14.24.3 Recent Development/News; 14.25 Viking Therapeutics; 14.25.1 Company Snapshots; 14.25.2 Revenue Analysis; 14.25.3 Product Portfolio; 14.25.4 Recent Development; 14.26 Zealand Pharma; 14.26.1 Company Snapshot; 14.26.2 Revenue Analysis; 14.26.3 Product Portfolio; 14.26.4 Recent Development/News
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 Obesity Prevalence By Region (Adults); Table 2 Obesity Prevalence By Gender (Adults); Table 3 Obesity Prevalence By Age (Adults); Table 4 Global Clinical Trial Market For Obesity Treatment; Table 5 Distribution Of Products And Projects By Phase Global Obesity Treatment Market; Table 6 Distribution Of Projects By Therapeutic Area And Phase Global Obesity Treatment Market; Table 7 Global Obesity Statistics (2022); Table 8 Global Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 9 Global Pharmacological Treatments (Anti-obesity Drugs) In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 10 Global Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 11 Global Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 12 Global Bariatric Surgery In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 13 Global Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 14 Global Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 15 Global Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 16 Global Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 17 Global Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 18 Global Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 19 Global Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 20 Global Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 21 Global Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 22 Global Medical Devices & Technologies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 23 Global Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 24 Global Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 25 Global Adult Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 26 Global Geriatric Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 27 Global Pediatric Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 28 Global Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 29 Global Online Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 30 Global Retail Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 31 Global Weight Management Clinics In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 32 Global Hospital Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 33 Global Wellness & Fitness Centers In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 34 Global Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 35 Global Class Iii In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 36 Global Class Ii In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 37 Global Class I In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 38 Global Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 39 North America Obesity Treatment Market, By Country, 2018-2032 (Usd Thousand); Table 40 North America Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 41 North America Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 42 North America Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 43 North America Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 44 North America Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 45 North America Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 46 North America Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 47 North America Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 48 North America Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 49 North America Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 50 North America Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 51 North America Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 52 North America Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 53 North America Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 54 U.S. Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 55 U.S. Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 56 U.S. Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 57 U.S. Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 58 U.S. Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 59 U.S. Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 60 U.S. Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 61 U.S. Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 62 U.S. Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 63 U.S. Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 64 U.S. Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 65 U.S Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 66 U.S. Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 67 U.S. Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 68 Mexico Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 69 Mexico Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 70 Mexico Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 71 Mexico Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 72 Mexico Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 73 Mexico Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 74 Mexico Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 75 Mexico Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 76 Mexico Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 77 Mexico Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 78 Mexico Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 79 Mexico Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 80 Mexico Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 81 Mexico Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 82 Canada Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 83 Canada Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 84 Canada Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 85 Canada Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 86 Canada Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 87 Canada Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 88 Canada Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 89 Canada Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 90 Canada Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 91 Canada Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 92 Canada Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 93 Canada Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 94 Canada Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 95 Canada Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 96 Europe Obesity Treatment Market, By Country, 2018-2032 (Usd Thousand); Table 97 Europe Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 98 Europe Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 99 Europe Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 100 Europe Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 101 Europe Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 102 Europe Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 103 Europe Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 104 Europe Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 105 Europe Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 106 Europe Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 107 Europe Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 108 Europe Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 109 Europe Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 110 Europe Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 111 United Kingdom Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 112 United Kingdom Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 113 United Kingdom Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 114 United Kingdom Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 115 United Kingdom Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 116 United Kingdom Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 117 United Kingdom Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 118 United Kingdom Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 119 United Kingdom Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 120 United Kingdom Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 121 United Kingdom Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 122 United Kingdom Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 123 United Kingdom Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 124 United Kingdom Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 125 Germany Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 126 Germany Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 127 Germany Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 128 Germany Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 129 Germany Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 130 Germany Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 131 Germany Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 132 Germany Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 133 Germany Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 134 Germany Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 135 Germany Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 136 Germany Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 137 Germany Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 138 Germany Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 139 France Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 140 France Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 141 France Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 142 France Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 143 France Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 144 France Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 145 France Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 146 France Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 147 France Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 148 France Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 149 France Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand)
List Of Figures: Figure 1 Asia-pacific Obesity Treatment Market: Segmentation; Figure 2 Asia-pacific Obesity Treatment Market: Data Triangulation; Figure 3 Asia-pacific Obesity Treatment Market: Droc Analysis; Figure 4 Asia-pacific Obesity Treatment Market: Regional Market Analysis; Figure 5 Asia-pacific Obesity Treatment Market: Company Research Analysis; Figure 6 Asia-pacific Obesity Treatment Market: Lifeline Curve; Figure 7 Asia-pacific Obesity Treatment Market: Interview Demographics; Figure 8 Asia-pacific Obesity Treatment Market: Dbmr Market Position Grid; Figure 9 Asia-pacific Obesity Treatment Market: Market End User Coverage Grid; Figure 10 Asia-pacific Obesity Treatment Market: Vendor Share Analysis; Figure 11 Asia-pacific Obesity Treatment Market: Segmentation; Figure 12 Asia-pacific Obesity Treatment Market Executive Summary; Figure 13 Strategic Decisions; Figure 14 Five Segments Comprise The Asia-pacific Obesity Treatment Market , By Treatment Type; Figure 15 Rising Prevalence Of Obesity Is Expected To Drive The Growth Of Asia-pacific Obesity Treatment Market From 2025 To 2032; Figure 16 The Pharmacological Treatments (Anti-obesity Drugs) Segment Is Expected To Account For The Largest Share Of The Asia-pacific Obesity Treatment Market In 2025 - 2032; Figure 17 Market Overview; Figure 18 Prevalence Of Obesity In Adults Age 20 And Older, By Sex And Age: United States, August 2021–august 2023 Source: Centers For Disease Control And Prevention.; Figure 19 Share Of Pre-obese And Obese Persons Aged 16 Years Or Over, By Sex, 2022 (%); Figure 20 Asia-pacific Obesity Treatment Market: By Treatment Type, 2024; Figure 21 Asia-pacific Obesity Treatment Market: By Treatment Type, 2025-2032 (Usd Thousand); Figure 22 Asia-pacific Obesity Treatment Market: By Treatment Type, Cagr (2025-2032); Figure 23 Asia-pacific Obesity Treatment Market: By Treatment Type, Lifeline Curve; Figure 24 Asia-pacific Obesity Treatment Market: By Age Group, 2024; Figure 25 Asia-pacific Obesity Treatment Market: By Age Group, 2025-2032 (Usd Thousand); Figure 26 Asia-pacific Obesity Treatment Market: By Age Group, Cagr (2025-2032); Figure 27 Asia-pacific Obesity Treatment Market: By Age Group, Lifeline Curve; Figure 28 Asia-pacific Obesity Treatment Market: By Distribution Channel, 2024; Figure 29 Asia-pacific Obesity Treatment Market: By Distribution Channel, 2025-2032 (Usd Thousand); Figure 30 Asia-pacific Obesity Treatment Market: By Distribution Channel, Cagr (2025-2032); Figure 31 Asia-pacific Obesity Treatment Market: By Distribution Channel, Lifeline Curve; Figure 32 Asia-pacific Obesity Treatment Market: By Patient Type, 2024; Figure 33 Asia-pacific Obesity Treatment Market: By Patient Type, 2025-2032 (Usd Thousand); Figure 34 Asia-pacific Obesity Treatment Market: By Patient Type, Cagr (2025-2032); Figure 35 Asia-pacific Obesity Treatment Market: By Patient Type, Lifeline Curve; Figure 36 Asia-pacific Obesity Treatment Market: Snapshot (2024); Figure 37 Asia-pacific Obesity Treatment Market: Company Share 2024 (%)

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now